Literature DB >> 19915216

The HALTS trial--halting atherosclerosis or halted too early?

Roger S Blumenthal, Erin D Michos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915216     DOI: 10.1056/NEJMe0908838

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Effect of extended-release niacin or ezetimibe on carotid intimal thickness: the ARBITER-HALTS Study.

Authors:  John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2010-09       Impact factor: 5.113

2.  Statins in combinations: from ARBITER-6 HALTS to ACCORD--what works?

Authors:  Michael Clearfield
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

3.  Further opportunities for cost reduction of medical care.

Authors:  M Malach; W J Baumol
Journal:  J Community Health       Date:  2010-12

4.  The utility of cardiopulmonary exercise testing to detect and track early-stage ischemic heart disease.

Authors:  Sundeep Chaudhry; Ross A Arena; James E Hansen; Gregory D Lewis; Jonathan N Myers; Laurence S Sperling; Brian D Labudde; Karlman Wasserman
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

5.  Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe.

Authors:  Philip Schwab; Anthony Louder; Yong Li; Rajiv Mallick; Harold Bays
Journal:  Drugs Aging       Date:  2014-09       Impact factor: 3.923

Review 6.  Inhibition of cholesterol absorption: targeting the intestine.

Authors:  Stephen D Lee; Pavel Gershkovich; Jerald W Darlington; Kishor M Wasan
Journal:  Pharm Res       Date:  2012-08-25       Impact factor: 4.200

7.  Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.

Authors:  Peter Willeit; Lena Tschiderer; Michael J Sweeting; Simon G Thompson; Matthias W Lorenz; Elias Allara; Kathrin Reuber; Lisa Seekircher; Lu Gao; Ximing Liao; Eva Lonn; Hertzel C Gerstein; Salim Yusuf; Frank P Brouwers; Folkert W Asselbergs; Wiek van Gilst; Sigmund A Anderssen; Diederick E Grobbee; John J P Kastelein; Frank L J Visseren; George Ntaios; Apostolos I Hatzitolios; Christos Savopoulos; Pythia T Nieuwkerk; Erik Stroes; Matthew Walters; Peter Higgins; Jesse Dawson; Paolo Gresele; Giuseppe Guglielmini; Rino Migliacci; Marat Ezhov; Maya Safarova; Tatyana Balakhonova; Eiichi Sato; Mayuko Amaha; Tsukasa Nakamura; Kostas Kapellas; Lisa M Jamieson; Michael Skilton; James A Blumenthal; Alan Hinderliter; Andrew Sherwood; Patrick J Smith; Michiel A van Agtmael; Peter Reiss; Marit G A van Vonderen; Stefan Kiechl; Gerhard Klingenschmid; Matthias Sitzer; Coen D A Stehouwer; Heiko Uthoff; Zhi-Yong Zou; Ana R Cunha; Mario F Neves; Miles D Witham; Hyun-Woong Park; Moo-Sik Lee; Jang-Ho Bae; Enrique Bernal; Kristian Wachtell; Sverre E Kjeldsen; Michael H Olsen; David Preiss; Naveed Sattar; Edith Beishuizen; Menno V Huisman; Mark A Espeland; Caroline Schmidt; Stefan Agewall; Ercan Ok; Gülay Aşçi; Eric de Groot; Muriel P C Grooteman; Peter J Blankestijn; Michiel L Bots
Journal:  Circulation       Date:  2020-06-17       Impact factor: 29.690

Review 8.  Effects of niacin on atherosclerosis and vascular function.

Authors:  Neil Ruparelia; Janet E Digby; Robin P Choudhury
Journal:  Curr Opin Cardiol       Date:  2011-01       Impact factor: 2.161

9.  Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol.

Authors:  Susan Kühnast; Mieke C Louwe; Mattijs M Heemskerk; Elsbet J Pieterman; Jan B van Klinken; Sjoerd A A van den Berg; Johannes W A Smit; Louis M Havekes; Patrick C N Rensen; José W A van der Hoorn; Hans M G Princen; J Wouter Jukema
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

Review 10.  Ezetimibe therapy: mechanism of action and clinical update.

Authors:  Binh An P Phan; Thomas D Dayspring; Peter P Toth
Journal:  Vasc Health Risk Manag       Date:  2012-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.